ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Molecular Viral Pathogenesis
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1578518
This article is part of the Research TopicGlobal Movement and the Spread of Vector-Borne Diseases: Challenges and StrategiesView all articles
First report of Crimean-Congo Haemorrhagic Fever Virus exposure in Human and Livestock Populations, Centre region, Cameroon
Provisionally accepted- 1University of Corsica Pascal Paoli, Corte, France
- 2INSERM U1207 Virus émergents (UVE), Marseille, Provence-Alpes-Côte d'Azur, France
- 3University of Buea, Buea, Cameroon
- 4Centre National de Référence des Arbovirus, Marseille, France
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Crimean-Congo haemorrhagic fever (CCHF) is a widespread, tick-borne viral infection present in many African countries. Its epidemiology and impact on public health remain poorly understood in Cameroon. The main objective of the current study was to investigate the circulation of CCHF virus (CCHFV) in ruminants (cattle and goats), humans and ticks collected simultaneously in a study area of Akonolinga, a health district in the Central Region of Cameroon.From the 15th to the 28th July 2024, a cross-sectional study was conducted in Akonolinga, by collecting survey data, serum samples (from humans, goats and cattle) and picking ticks from cattle and goats. This study included 100 randomly selected households from eight localities.Data were also collected using questionnaires to assess CCHFV seropositivity associated factors. Individual characteristics of 189 goats and 246 cattle were collected and the data georeferenced. To assess the prevalence of CCHF, serological (ELISA) and molecular (real time RT PCR) methods were used to detect antibodies targeting CCHF viral nucleoprotein and CCHFV specific RNA in collected sera, respectively. The presence of CCHFV specific RNA was also assessed in tick homogenate using real time RT PCR.The overall CCHFV seroprevalence was 1.9% [(95% CI (1.02%-3.64%)] in humans, 10.9% [(n=42 ;] in cattle and of 3.38% [(n=5 ; 95% CI (1.45%-7.66%)] in goats. Seroprevalence in cattle increased significantly with age. A total of 554 ticks were collected from 162 of the 386 (42%) cattle examined, with Rhipicephalus (Boophilus) microplus being the dominant species. CCHFV RNA was detected in two sera of women sampled. Phylogenetic analysis of a small portion of the L segment classified the strain within the African genotype III.This study reported for the first-time the proven exposure of the human population to CCHFV in central Cameroon, showing strong evidence that CCHFV is infecting humans. Serological analyses revealed exposure of cattle and goats to CCHFV-strains collected in the same geographical area. These results demonstrate the potential risk of CCHF emergence in the human population, especially in rural areas in close vicinity with animals.
Keywords: CCHFV, Cattle, Humans, Goats, Ticks, Cameroon, One Health, Akonolinga
Received: 17 Feb 2025; Accepted: 14 May 2025.
Copyright: © 2025 GASPARINE, Namekong-Fokeng, Lopez, Mvodo, Thirion, Paguem, Charrel, De Lamballerie and Falchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Moréna GASPARINE, University of Corsica Pascal Paoli, Corte, France
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.